Section Review: Oncologic, Endocrine and Metabolic Adrenoceptors and imidazoline binding sites in the endocrine pancreas as targets for anti-hyperglycaemic drugs
- 1 June 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (6) , 561-569
- https://doi.org/10.1517/13543784.3.6.561
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of LangerhansJournal of Endocrinology, 1993
- ADRENOCEPTORS AS MODELS FOR G PROTEIN-COUPLED RECEPTORS: STRUCTURE, FUNCTION AND REGULATIONBritish Journal of Anaesthesia, 1993
- Anti-Obesity and Anti-Diabetic Actions of a .BETA.3-Adrenoceptor Agonist, BRL 26830A, in Yellow KK Mice.Endocrinologia Japonica, 1991
- Differential effects of β-adrenergic agonists on insulin secretion from pancreatic islets isolated from rat and manJournal of Molecular Endocrinology, 1990
- Regulation of insulin secretion by α2-adrenergic agonistsTrends in Pharmacological Sciences, 1987
- Metabolic and Cardiovascular Responses to Epinephrine in Diabetic Autonomic NeuropathyNew England Journal of Medicine, 1987
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984
- Pancreatic Neuroendocrinology: Peripheral Neural Mechanisms in the Regulation of the Islets of Langerhans*Endocrine Reviews, 1981
- A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.Journal of Clinical Investigation, 1976
- Effect of α-adrenergic blockade on insulin secretion in manMetabolism, 1970